Baseline lab investigations: HbA1c, thyroid function, liver enzymes, kidney function, and lipid profile
Both drugs are in the GLP-1 agonist class, which mimics hormones in the gut to regulate appetite and blood sugar levels
Extensive evidence suggests that LA may have therapeutic usefulness in lowering blood glucose levels in diabetic conditions and that the intracellular redox status plays a role in the modulation of insulin resistance
Pfizer moves forward a daily GLP-1 obesity pill Pfizer will advance a once-daily formulation of its oral GLP-1 obesity candidate, danuglipron, after facing multiple setbacks in the space
Some of the side effects we found, like nausea, are well known, and that shows the method is picking up a real signal, said senior author Sharath Chandra Guntuku in a press release
These medications have undergone extensive FDA review and have demonstrated consistent dosing and safety across large clinical trials